Guillain-Barre Syndrome Therapeutics Market Report 2021 – Global Trajectory & Analytics, 2012-2019 & 2020-2027 – ResearchAndMarkets.com

DUBLIN–()–The “Guillain-Barre Syndrome Therapeutics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s providing.

Global Guillain-Barre Syndrome Therapeutics Market to Reach $679.6 Million by 2027

Amid the COVID-19 disaster, the worldwide marketplace for Guillain-Barre Syndrome Therapeutics estimated at US$491.1 Million within the 12 months 2020, is projected to succeed in a revised dimension of US$679.6 Million by 2027, rising at a CAGR of 4.7% over the evaluation interval 2020-2027.

Intravenous Immunoglobulin, one of many segments analyzed within the report, is projected to report a 5% CAGR and attain US$383.3 Million by the tip of the evaluation interval. After an early evaluation of the enterprise implications of the pandemic and its induced financial disaster, progress within the Plasma Exchange section is readjusted to a revised 4.6% CAGR for the subsequent 7-year interval.

The U.S. Market is Estimated at $144.7 Million, While China is Forecast to Grow at 4.5% CAGR

The Guillain-Barre Syndrome Therapeutics market within the U.S. is estimated at US$144.7 Million within the 12 months 2020. China, the world’s second largest financial system, is forecast to succeed in a projected market dimension of US$120.4 Million by the 12 months 2027 trailing a CAGR of 4.5% over the evaluation interval 2020 to 2027. Among the opposite noteworthy geographic markets are Japan and Canada, every forecast to develop at 4.4% and 4% respectively over the 2020-2027 interval. Within Europe, Germany is forecast to develop at roughly 4.5% CAGR.

Other Therapeutics Segment to Record 3.9% CAGR

In the worldwide Other Therapeutics section, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this section. These regional markets accounting for a mixed market dimension of US$56 Million within the 12 months 2020 will attain a projected dimension of US$73.6 Million by the shut of the evaluation interval. China will stay among the many quickest rising on this cluster of regional markets. Led by nations akin to Australia, India, and South Korea, the market in Asia-Pacific is forecast to succeed in US$75.8 Million by the 12 months 2027.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 42 Featured):

  • Akari Therapeutics Plc
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • CSL Behring LLC
  • Grifols SA
  • Kedrion SpA
  • Nihon Pharmaceutical Co., Ltd.
  • Octapharma AG
  • Shire PLC

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • World 15-Year Perspective for Intravenous Immunoglobulin by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Plasma Exchange by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Other Therapeutics by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Hospital Pharmacies by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Retail Pharmacies by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 42

For extra details about this report go to https://www.researchandmarkets.com/r/k0lbs3

LEAVE A REPLY

Please enter your comment!
Please enter your name here